This invention belongs to the field of
biomedicine, and specifically relates to the application of FeTMPyP in the preparation of drugs to alleviate ovarian
toxicity. This application addresses the issue that combined
exposure to MC-LR and NaNO₂ significantly induces
nitrification stress in mouse ovaries, leading to follicular barrier disruption and ovarian reproductive endocrine dysfunction. FeTMPyP was selected as an intervention agent, which effectively alleviated
nitrification stress induced by combined
exposure to MC-LR and NaNO₂ in mouse ovaries, and improved sex
hormone disorders,
estrous cycle irregularities, and follicular
atresia caused by the combined
exposure to these two toxins. Simultaneously, it restored the
fertility of mice, indicating that FeTMPyP intervention can alleviate ovarian
toxicity induced by combined exposure to MC-LR and NaNO₂ in mice. This invention can be used to prepare drugs to prevent and treat diseases related to ovarian
toxicity caused by environmental
toxin exposure in mice, providing a new approach for the early identification and targeted intervention of ovarian-related diseases.